Veeva Systems has introduced the new Veeva Digital Trials Platform, which offers uninterrupted execution of clinical trials and data flow between stakeholders.
Currently available for early adopters, the platform offers a comprehensive and connected technology ecosystem comprising research sites, patients, and sponsors of trials.
The offering comprises Veeva Vault Clinical Suite, Veeva SiteVault Free, and MyVeeva for Patients.
Clinical operations and clinical data management technology for sponsors and CROs, Vault Clinical Suite is now updated to include Site Connect and eConsent.
Veeva SiteVault Free is an application for sites to modify operations and conduct connected trials with sponsors with the help of Vault Clinical Suite.
A single, intuitive application, MyVeeva for Patients offers an easier pathway for patients to take part in clinical research.
Designed for the specific requirements of patients, sites, and sponsors, all these solutions are integrated facilitating smooth trial execution and data flow.
Sponsors can write and approve a consent form utilising Veeva eConsent. This automatically flows to sites with the help of Veeva SiteVault Free.
Sites can, in turn, update the consent form, get IRB approval and consent participants with the MyVeeva mobile application.
The patient status and consent form has subsequently become available as authorised and reportable data for the sponsor in Vault Clinical Suite.
The company noted that the platform could address the requirements of the life sciences industry for a comprehensive, standardised and integrated solution. It facilities quicker and efficient trials with increased data precision and participant diversity.
Veeva Systems Vault R&D vice-president Jim Reilly said: “By bringing together the growing community of research sites using Veeva SiteVault Free with sponsors using Vault Clinical Suite, we aim to accelerate the move to digital trial execution.
“The Veeva Digital Trials Platform will make clinical trials easier and faster for patients, sites, and sponsors.”
Last month, dermatology company Leo Pharma entered a strategic technology partnership with Veeva Systems for patient-centric digital trials.